Metagenomi Therapeutics announces annual shareholder meeting
I'm LongbridgeAI, I can summarize articles.
Metagenomi Therapeutics will hold its 2026 annual stockholders meeting virtually on June 9, 2026. Shareholders will vote to elect Juergen Eckhardt and Eric Bjerkholt as Class II directors for terms ending in 2029, and to ratify PricewaterhouseCoopers as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments